Literature DB >> 22868709

Transplantation: is donor T-cell engraftment a biomarker for tolerance?

Hong Xu1, Suzanne T Ildstad.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22868709     DOI： 10.1038/nrneph.2012.187

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism.

Authors:  Hong Xu; Paula M Chilton; Yiming Huang; Carrie L Schanie; Suzanne T Ildstad
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

2.  Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques.

Authors:  S K Ramakrishnan; A Page; A B Farris; K Singh; F Leopardi; K Hamby; S Sen; A Polnett; T Deane; M Song; L Stempora; E Strobert; A D Kirk; C P Larsen; L S Kean
Journal:  Am J Transplant       Date:  2012-05-29       Impact factor: 8.086

3.  Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.

Authors:  Joseph Leventhal; Michael Abecassis; Joshua Miller; Lorenzo Gallon; Kadiyala Ravindra; David J Tollerud; Bradley King; Mary Jane Elliott; Geoffrey Herzig; Roger Herzig; Suzanne T Ildstad
Journal:  Sci Transl Med       Date:  2012-03-07       Impact factor: 17.956

4.  Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts.

Authors:  S T Ildstad; D H Sachs
Journal:  Nature       Date:  1984 Jan 12-18       Impact factor: 49.962

5.  Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation.

Authors:  A Umemura; H Morita; X C Li; S Tahan; A P Monaco; T Maki
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

6.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

7.  Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.

Authors:  Hong Xu; Paula M Chilton; Yiming Huang; Carrie L Schanie; Jun Yan; Suzanne T Ildstad
Journal:  Transplantation       Date:  2007-04-15       Impact factor: 4.939

8.  Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases.

Authors:  Dietger Niederwieser; Michael Maris; Judith A Shizuru; Effie Petersdorf; Ute Hegenbart; Brenda M Sandmaier; David G Maloney; Barry Storer; Thoralf Lange; Thomas Chauncey; Michael Deininger; Wolfram Pönisch; Claudio Anasetti; Ann Woolfrey; Marie-Terese Little; Karl G Blume; Peter A McSweeney; Rainer F Storb
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

9.  Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders.

Authors:  E Ozyurek; M J Cowan; M A Koerper; L-A Baxter-Lowe; C C Dvorak; B N Horn
Journal:  Bone Marrow Transplant       Date:  2008-04-07       Impact factor: 5.483

10.  CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.

Authors:  Christoph Jochum; Mechthild Beste; Eustacia Zellmer; Scott S Graves; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2007-02       Impact factor: 5.742
  10 in total
  5 in total

1.  Facilitating cells: Translation of hematopoietic chimerism to achieve clinical tolerance.

Authors:  Suzanne T Ildstad; Joseph Leventhal; Yujie Wen; Esma Yolcu
Journal:  Chimerism       Date:  2016-01-08

Review 2.  Operational tolerance in kidney transplantation and associated biomarkers.

Authors:  A Massart; L Ghisdal; M Abramowicz; D Abramowicz
Journal:  Clin Exp Immunol       Date:  2017-05-29       Impact factor: 4.330

Review 3.  Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance.

Authors:  J Leventhal; J Miller; M Abecassis; D J Tollerud; S T Ildstad
Journal:  Clin Pharmacol Ther       Date:  2012-10-10       Impact factor: 6.875

4.  T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model.

Authors:  Nina Pilat; Andreas M Farkas; Benedikt Mahr; Christoph Schwarz; Lukas Unger; Karin Hock; Rupert Oberhuber; Klaus Aumayr; Fritz Wrba; Thomas Wekerle
Journal:  J Heart Lung Transplant       Date:  2013-11-28       Impact factor: 10.247

Review 5.  Transplantation tolerance.

Authors:  Emma M Salisbury; David S Game; Robert I Lechler
Journal:  Pediatr Nephrol       Date:  2013-11-10       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.